Medical News

RSS

ETMC to implement Unibased's Consumer Access and Scheduling for Healthcare web application

East Texas Medical Center (ETMC) has announced its selection of Unibased Systems Architecture, Inc. (Unibased) consumer portal, Consumer Access and Scheduling for Healthcare (CASH) to simplify and expedite access for services. The web application is fully integrated with the Unibased ForSite2020® product suite and it will improve the access process. Providing 24/7 web access to service scheduling and registration eliminates several of the impediments consumers experience in obtaining their healthcare needs.

29 Oct 2009

Alnylam Pharmaceuticals announces participation in a $2.4M cardiovascular disease research grant

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today its participation in a $2.4 million research grant awarded to the University of Pennsylvania under the “American Recovery and Reinvestment Act of 2009”. The new grant will fund research over two years in the laboratories of Daniel Rader, M.D. of the University of Pennsylvania School of Medicine, Sekar Kathiresan, M.D. of Massachusetts General Hospital (MGH) and Harvard Medical School, and Alnylam.

29 Oct 2009

Gamma Pharmaceuticals completes the registration of six of its Brand Trademarks in China

Gamma Pharmaceuticals Inc. (the "Company") announced it has successfully completed the registration of six of the Company's Brand Trademarks with The State Trademark Bureau of China.

29 Oct 2009

Amorfix Life Sciences achieves 100% specificity in using EP-vCJD Blood Screening Assay

Amorfix Life Sciences, a company focused on treatments and diagnostics for misfolded protein diseases, today announced it has achieved 100% specificity (no reproducible false positive results) upon testing 19,000 blood donations for variant Creutzfeldt-Jakob Disease ("vCJD") with the EP-vCJD(TM) Blood Screening Assay at l'Etablissement Français du Sang de Pyrénées Méditerrannée ("EFS-PM") in Montpellier, France.

29 Oct 2009

Novian Health and Rose Medical Center sign an agreement to provide Novilase laser treatment to treat breast lumps

Novian Health, manufacturer of Novilase™ Breast Therapy for benign breast tumors, announced an agreement with Rose Medical Center for Rose to provide the Novilase laser treatment to treat breast lumps.

29 Oct 2009

Merge Healthcare reports fiscal 2009 third-quarter results

Merge Healthcare Incorporated, a health IT solutions provider, today announced financial results for the third quarter of 2009.

29 Oct 2009

Third-quarter fiscal 2009 results announced by Adolor

Adolor Corporation today reported a net loss of approximately $11.1 million, or ($0.24) per basic and diluted share, for the three months ended September 30, 2009 compared to a net loss of $13.3 million, or ($0.29) per basic and diluted share, for the three months ended September 30, 2008.

29 Oct 2009

ZyGEM signs an agreement with VERITAS Japan to distribute DNA extraction products to the Japanese market

ZyGEM Corp. Ltd., a provider of innovative enzyme-based products for DNA extraction and other life sciences applications, today announced it has entered into an exclusive agreement with VERITAS Japan to distribute ZyGEM's DNA extraction products to the Japanese market.

29 Oct 2009

Gruve, an activity-based weight management solution from Muve

Muve, Inc., the activity-based weight management company, continues to see increased interest in measurable, sustainable wellness solutions by employers trying to reduce employee health care costs. Muve’s product, the Gruve Solution, helps corporate clients and their employees to become more healthy and productive, while reducing health care costs through measurable results.

29 Oct 2009

NovaMed announces results for the third quarter ended September 30, 2009

NovaMed, Inc., a leading operator of ambulatory surgery centers in partnership with physicians, today announced results for the third quarter ended September 30, 2009. Total net revenue grew to $38,768,000, up 8% from $36,050,000 in the prior year third quarter.

29 Oct 2009

Promedior granted European Orphan Medicinal Product Designation for PRM-151

Promedior, Inc., a leader in the development of novel therapeutics for the treatment of fibrotic diseases and tissue remodeling, announced today that the European Commission has granted Orphan Medicinal Product Designation to its lead drug candidate PRM-151 for use in the prevention of scarring post glaucoma filtration surgery.

29 Oct 2009

NMT Medical reports financial results for third-quarter 2009; narrows net loss to $0.22 per share

NMT Medical, Inc., an advanced medical technology company that designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive, catheter-based procedures, today announced financial results for the quarter and nine months ended September 30, 2009.

29 Oct 2009

Roger Tung to receive 2009 Mass High Tech All Star award for his contributions to pharmaceutical industry

Concert Pharmaceuticals, Inc. announced today that Roger Tung, Ph.D., President and Chief Executive Officer, has been named a 2009 Mass High Tech All Star for his contributions to the pharmaceutical industry.

29 Oct 2009

Study looks at the impact of health insurance on the number of preventable deaths in the U.S.

Lack of health insurance might have led or contributed to nearly 17,000 deaths among hospitalized children in the United States in the span of less than two decades, according to research led by the Johns Hopkins Children's Center.

29 Oct 2009

Third-quarter fiscal 2009 results announced by Endo Pharmaceuticals

Endo Pharmaceuticals today reported financial results for the third quarter of 2009.

29 Oct 2009

Record third-quarter fiscal 2009 results announced by Nu Skin Enterprises

Nu Skin Enterprises, Inc. today announced record third-quarter revenue of $334.2 million, an 8 percent improvement over the prior-year period. Revenue in the period benefited 1 percent from foreign currency fluctuations. Earnings per share for the quarter were $0.40, a 54 percent improvement over the same quarter of 2008. Earnings per share, excluding restructuring charges of $0.01, were $0.41, a 58 percent improvement over the prior-year period.

29 Oct 2009

New herbal medicinal product for reducing mental and physical stress

Marketed under the trade name Vitango® and now available from pharmacies, the product is a special extract of a highly resilient plant called Golden Root (Rhodiola rosea) that grows in the freezing conditions of Northern Europe and Asia's mountain peaks.

29 Oct 2009

WaveMark CIMS implemented at St. Joseph’s Hospital

WaveMark, Inc., a leading provider of real-time inventory management (RTIM) solutions for high value medical products, and St. Joseph’s Hospital of Atlanta, GA today announced the use of WaveMark’s hospital inventory management solution, WaveMark CIMS™, by St. Joseph’s Hospital to manage its high value, specialty inventory. St. Joseph’s will use WaveMark’s point of use RTIM technology to track physician preference items in its Cardiac Cath and Electrophysiology (EP) labs.

29 Oct 2009

Xenomics sues Sequenom

Xenomics, Inc. a developer of trans-renal molecular diagnostic technologies, announced today that it has filed a complaint against Sequenom, Inc. in the Supreme Court of the State of New York alleging that Sequenom fraudulently misrepresented to Xenomics the status of its testing for Down Syndrome and based upon such conduct, Xenomics was induced to enter into a license agreement with Sequenom thereby giving up various valuable patent rights.

29 Oct 2009

Unaudited consolidated financial results for the third-quarter reported by AMAG Pharmaceuticals

AMAG Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today reported unaudited consolidated financial results for the third quarter and nine months ended September 30, 2009.

29 Oct 2009

Medical News

ETMC to implement Unibased's Consumer Access and Scheduling for Healthcare web application

Alnylam Pharmaceuticals announces participation in a $2.4M cardiovascular disease research grant

Gamma Pharmaceuticals completes the registration of six of its Brand Trademarks in China

Amorfix Life Sciences achieves 100% specificity in using EP-vCJD Blood Screening Assay

Novian Health and Rose Medical Center sign an agreement to provide Novilase laser treatment to treat breast lumps

Merge Healthcare reports fiscal 2009 third-quarter results

Third-quarter fiscal 2009 results announced by Adolor

ZyGEM signs an agreement with VERITAS Japan to distribute DNA extraction products to the Japanese market

Gruve, an activity-based weight management solution from Muve

NovaMed announces results for the third quarter ended September 30, 2009

Promedior granted European Orphan Medicinal Product Designation for PRM-151

NMT Medical reports financial results for third-quarter 2009; narrows net loss to $0.22 per share

Roger Tung to receive 2009 Mass High Tech All Star award for his contributions to pharmaceutical industry

Study looks at the impact of health insurance on the number of preventable deaths in the U.S.

Third-quarter fiscal 2009 results announced by Endo Pharmaceuticals

Record third-quarter fiscal 2009 results announced by Nu Skin Enterprises

New herbal medicinal product for reducing mental and physical stress

WaveMark CIMS implemented at St. Joseph’s Hospital

Xenomics sues Sequenom

Unaudited consolidated financial results for the third-quarter reported by AMAG Pharmaceuticals

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News